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T follicular helper (Tfh) cells are essential for efficient
B cell responses, yet the factors that regulate differ-
entiation of this CD4+ T cell subset are incompletely
understood. Here we found that the KLF2 transcrip-
tion factor serves to restrain Tfh cell generation.
Induced KLF2 deficiency in activated CD4+ T cells
led to increased Tfh cell generation and B cell prim-
ing, whereas KLF2 overexpression prevented Tfh
cell production. KLF2 promotes expression of the
trafficking receptor S1PR1, and S1PR1 downregula-
tion is essential for efficient Tfh cell production. How-
ever, KLF2 also induced expression of the transcrip-
tion factor Blimp-1, which repressed transcription
factor Bcl-6 and thereby impaired Tfh cell differenti-
ation. Furthermore, KLF2 induced expression of the
transcription factors T-bet andGATA3 and enhanced
Th1 differentiation. Hence, our data indicate KLF2
is pivotal for coordinating CD4+ T cell differentiation
through two distinct and complementary mecha-
nisms: via control of T cell localization and by regula-
tion of lineage-defining transcription factors.
INTRODUCTION
During the immune response toward foreign antigens, the
germinal center (GC) reaction represents a central mechanism
for generating high-affinity antibodies of diverse isotypes (Vic-
tora and Nussenzweig, 2012). Fundamental in this process is
the activity of CD4+ T follicular helper (Tfh) cells, which coordi-
nate generation of the GC, initiate help for antigen-specific B
cells, and promote selection of germinal-center B cell clones
that have developed enhanced antigen recognition through so-
matic hypermutation (Crotty, 2011; Liu et al., 2013; Victora and
Nussenzweig, 2012; Vinuesa and Cyster, 2011). Characteristic
features of Tfh cells include expression of inducible T cell co-
stimulator (ICOS), programmed death 1 (PD-1), the chemokine
receptor CXCR5, and the cytokine interleukin-21 (IL-21), and
these molecules are key for Tfh cell generation and function252 Immunity 42, 252–264, February 17, 2015 ª2015 Elsevier Inc.(Crotty, 2011; Liu et al., 2013; Victora and Nussenzweig, 2012;
Vinuesa and Cyster, 2011). Cells with a Tfh cell phenotype accu-
mulate around and enter B cell follicles, whereas cells that
localize within GC are characterized by high expression of
CXCR5, PD-1, and Bcl-6 (Crotty, 2011; Liu et al., 2013; Victora
and Nussenzweig, 2012; Vinuesa and Cyster, 2011). Migration
and retention of Tfh in the GC depends on CXCR5 and the sphin-
gosine-1-phosphate receptor S1PR2 (Moriyama et al., 2014)
Downregulation of CCR7 is also critical for Tfh cell accumulation
in the follicle and normal GC responses (Haynes et al., 2007);
however, other factors that negatively regulate Tfh cell trafficking
are not well defined.
Multiple transcription factors, including c-Maf, Batf, Irf4,
STAT1, STAT3, and Ascl2, are involved in development and
function of Tfh cells (Crotty, 2011; Liu et al., 2014; Liu et al.,
2013), but maintenance and full differentiation of Tfh critically re-
quires expression of Bcl-6 (Choi et al., 2011; Crotty, 2011; Liu
et al., 2014; Liu et al., 2013; Liu et al., 2012; Vinuesa and Cyster,
2011). The Tfh differentiation pathway is opposed by other fac-
tors, the best studied of which is Blimp-1. Bcl-6 and Blimp-1
are mutually antagonistic, making the balance in expression of
these two factors a critical element in determining the fate of
helper T cells. IL-2R signaling impairs Tfh generation in a mech-
anism involving Blimp-1 and STAT5 (Ballesteros-Tato et al.,
2012; Johnston et al., 2012; Oestreich et al., 2012; Pepper
et al., 2011). Furthermore, the transcription factors Foxo1 and
Foxp1 both restrain Tfh cell generation, although the mecha-
nisms involved are not fully defined (Kerdiles et al., 2010;
Wang et al., 2014; Xiao et al., 2014). Activated CD4+ T cells
that do not mature into Tfh cells can join one of several alterna-
tive ‘‘non-Tfh’’ subsets (including T helper 1 [Th1], Th2, Th17, and
Treg cells) that are thought to not localize into the GC. Key tran-
scription factors for several of these alternative fates are blocked
by Bcl-6 (Crotty, 2011; Liu et al., 2013; Nurieva et al., 2009),
further establishing this factor as central to reinforcing Tfh
differentiation.
Hence, in order to effectively participate in the GC response,
Tfh cells must (1) migrate into the B cell follicle and reside in
the GC; (2) acquire specific functional properties needed for
effective B cell help; and (3) exclude alternative differentiation
fates. It is unclear, however, whether these three aspects are
coordinately regulated and, if so, what factors are involved in
that control.
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Figure 1. KLF2 Is Downregulated in Tfh
Cells
KLF2-GFP reporter mice were infected with
LCMV (A–D) or recombinant Listeria mono-
cytogenes expressing the 2W1S epitope (LM-
2W1S) (D) and analyzed 7 days later. (A) Antigen-
specific splenic CD8+ and CD4+ T cells were
enriched via Db-GP33 and I-Ab-GP66 tetramers,
respectively, and monitored for KLF2-GFP ex-
pression. Shadow area shows background GFP
signal in non-transgenic wild-type (WT) controls.
(B) CXCR5, PD-1, and Bcl-6 expression is shown
for total, KLF2-GFPlo-specific, and KLF2-GFPhi
LCMV-specific CD4+ T cells. (C) KLF2-GFP ex-
pression by cells with (CXCR5hiPD-1+) or without
(CXCR5-PD-1) a Tfh cell phenotype in I-Ab-
GP66 tetramer+ CD4+ T cells from LCMV-in-
fected mice. Numbers indicate the geometric
mean fluorescence intensity (gMFI) of KLF2-GFP
expressed in each population. In (D), KLF2-GFP
expression is shown for cells with and without a
Tfh cell phenotype for the LCMV-specific CD4+
T cells (left) and for I-Ab-2W1S tetramer+ and I-
Ab-LLO tetramer+ CD4+ T cells in LM-2W1S-in-
fected mice (right). Data are shown as gMFI
minus background gMFI of WT CD4+ T cells.
Data are from at least three independent ex-
periments with a total of 13 (A–D for LCMV
infection) or 8 (D for LM-2W1S infection) KLF2-
GFP reporter mice and are representative of (A–C) or accumulated from (D) the independent experiments as the mean ± SEM. Statistical significance,
determined with a two-tailed t test, is indicated as follows: ns, not significant (p > 0.05); and ***p < 0.001.The transcription factor KLF2 is essential for naive T cell traf-
ficking, in part through promoting expression of CD62L (L-selec-
tin) and S1PR1, which are critical for lymphocyte entry and
egress, respectively, in secondary lymphoid tissues (Bai et al.,
2007; Carlson et al., 2006; Hart et al., 2012; Takada et al.,
2011). More recently, we reported that low expression of KLF2
and S1PR1 were prerequisite for effective generation of tissue-
resident memory CD8+ T (Trm) cells—a population that is prom-
inent in nonlymphoid tissues and does not recirculate via the
blood and lymph (Skon et al., 2013). Those studies suggested
that T-lymphocyte residence and recirculation were character-
ized by low and high expression of KLF2, respectively. Similarly,
in order to provide sustained help for GC B cells, Tfh cells must
become a resident population within the responding lymphoid
tissue. Hence, in this report we explore whether KLF2 impacts
the capacity of activated CD4+ T cells to become Tfh cells. We
found that KLF2 expression impairs Tfh cell differentiation and
that KLF2 deficiency enhances Tfh cell generation. These effects
relate to the capacity of KLF2 to induce expression of Blimp-1;
however, we also showed that KLF2 promotes expression of
T-bet and GATA3, indicating that KLF2 controls various aspects
of Th cell differentiation.
RESULTS
Tfh Cells Exhibit a KLF2lo Phenotype
We initially studied KLF2 expression in antigen-specific CD4+
and CD8+ T cells responding to lymphocytic choriomeningitis
virus (LCMV) by using a previously described KLF2-GFP reporter
mouse strain (Skon et al., 2013; Weinreich et al., 2009). In keep-ingwith our earlier findings (Skon et al., 2013), the vastmajority of
effector CD8+ T cells in lymphoid tissues expressed KLF2 (Fig-
ure 1A), yet we noted that KLF2 expression in effector CD4+
T cells was bimodal, in that some cells expressed KLF2 in
amounts similar to those observed in the CD8+ T cell population,
whereas other cells exhibited substantially reduced KLF2 ex-
pression (Figure 1A). We have reported that KLF2 downregula-
tion characterized non-recirculating Trm (Skon et al., 2013),
and the B cell helper function of Tfh cells obliges them to be re-
tained within the priming lymphoid tissue (Crotty, 2011; Victora
and Nussenzweig, 2012). Hence we investigated whether the
amount of KLF2 expressed correlated with the Tfh cell subset.
Indeed, we found that the KLF2lo subset was highly enriched
for cells expressing a Tfh cell phenotype (CXCR5hi, PD-1hi, and
Bcl-6hi), whereas non-Tfh cells weremore prevalent in the KLF2hi
population (Figure 1B). Further analysis showed that cells with a
Tfh cell phenotype were KLF2lo, whereas non-Tfh-cell popula-
tions expressed higher amounts of KLF2 (Figures 1B and 1C).
Cells in the CXCR5int, PD-1lo population are likely to be a mixture
of developing Tfh cells and precursors for central memory CD4+
T cells (Crotty, 2011; Pepper and Jenkins, 2011) and hence are
not further discussed. This expression pattern was not limited
to CD4+ T cells responding to LCMV in light of the fact that we
observed similar profiles for polyclonal CD4+ T cells responding
to distinct epitopes during acute infection with the bacteria Lis-
teria monocytogenes (Figure 1D).
To extend these findings and visualize differences in KLF2
expression in the context of lymphoid tissue architecture, we
used immunohistochemistry to determine KLF2-GFP expression
in situ in the draining lymph node after immunization with theImmunity 42, 252–264, February 17, 2015 ª2015 Elsevier Inc. 253
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Figure 2. KLF2 Expression by CD4+ T Cells
Is Reduced in the GC Compared to the T
Cell Zone
Immunohistochemistry analysis of a draining lymph
node (dLN) from KLF2-GFP reporter mice immu-
nized subcutaneously with Phycoerythrin (PE)
14 days earlier.
(A) In the left image, the indicated stains were used
for identification of B cell follicles (B220+) and the
T cell zone (B220-, CD4+), whereas germinal centers
(GCs) were identified by GL7 staining (and con-
firmed by PE co-staining: data not shown). Two
GCs are indicated by white arrows. The right image
is the same section, but only the KLF2-GFP staining
signal is shown.
(B) The panels show the staining for KLF2-GFP
(green) and CD4+ (red) for cells in the GC or T cell
zone, as indicated. The upper two panels are from
immunized KLF2-GFP mice, whereas the lower two
panels are from immunized WT B6 mice. Colors are
as follows: gray, DAPI; purple, B220; green, KLF2-
GFP; red, CD4; and blue, GL7. The scale bars for
the images are shown.
(C) The KLF2-GFP fluorescence intensity of CD4+
T cells in the GC or T cell zone (according to the
criteria defined in [A and B]). Each dot represents a
single CD4+ T cell, and the red bar indicates the
average fluorescence intensity of each group. All
experiments were repeated three times with similar
results. Graphs show accumulated data from three
independent experiments as means ± SEM; ***p <
0.001 per a two-tailed t test.protein Phycoerythrin (Figure S1). CD4+ T cells that were physi-
cally localized to the GC had significantly lower KLF2 expression
than CD4+ T cells located in the T cell zone (Figures 2A and 2B).
Indeed, GFP expression was clearly lower in the GC as a whole,
indicating that both CD4+ T cells and B cells in this zone were
KLF2lo (Figures 2B and 2C). Collectively, these data suggested
that the reduced KLF2 expression is a signature feature of the
Tfh cell population.
Dynamic Changes in KLF2 and S1PR1Expression during
the CD4+ T Cell Response
To further investigate the regulation and function of KLF2 during
CD4+ T cell lineage commitment, we developed an adoptive
transfer systemby using TCR transgenic CD4+ T cells (TEa), spe-
cific for I-Ab-Ea (Grubin et al., 1997). To enhance antigen-spe-
cific B cell interactions and optimize Tfh cell differentiation
(Crotty, 2011; Victora and Nussenzweig, 2012), we co-trans-
ferredMD4BCR transgenic B cells that recognize duck egg lyso-
zyme (DEL) (Hartley et al., 1991), and immunized the recipient
mice with a conjugate antigen (Ea-DEL) bearing antigens for
both TEa andMD4 cells (Figures S2A–S2C).We used this system
to define the kinetics of KLF2 and S1PR1 expression in vivo,
through adoptive transfer of KLF2-GFP (Skon et al., 2013; Wein-
reich et al., 2009) or S1PR1-GFP reporter (Cahalan et al., 2011)
TEa CD4+ T cells. At an early activation stage (day 2), primed
TEa cells uniformly reduced KLF2 and S1PR1 reporter expres-
sion in secondary lymphoid organs (Figure 3A), in keeping with
previous data on KLF2 and S1PR1 downregulation after TCR254 Immunity 42, 252–264, February 17, 2015 ª2015 Elsevier Inc.engagement (Cahalan et al., 2011; Cyster and Schwab, 2012;
Skon et al., 2013). From day 5 of the response, however, cells
without a Tfh cell phenotype showed sustained KLF2 re-expres-
sion, whereas cells with a Tfh cell phenotype maintained low
KLF2 reporter expression well into the memory phase (day 30).
S1PR1 reporter expression was also markedly lower in Tfh cells
than in the non-Tfh-cell population (Figure 3A), consistent with
the very low KLF2 expression in the Tfh cell population.
We also observed higher expression of the activation marker
CD69 in Tfh cells than in non-Tfh-effector-cell populations (Fig-
ure 3B). Studies suggest TCR engagement is required for sus-
taining Tfh proliferation and maintenance (Choi et al., 2013),
and it has been proposed that CD69 expression on Tfh cells
is an indication of TCR stimulation (Fazilleau et al., 2009).
This is relevant because TCR signals cause KLF2 downregula-
tion. However, CD69 and S1PR1 inhibit each other’s cell-sur-
face expression, and loss of S1PR1 results in elevated basal
CD69 expression (Bankovich et al., 2010; Pham et al., 2008;
Skon et al., 2013), complicating interpretation of the CD69+
phenotype. Hence, we also looked for evidence of recent
TCR signaling by using the Nur77-GFP reporter transgenic
system (Moran et al., 2011). By day 14 of the response, we
saw evidence of sustained TCR signaling in the Tfh cell pool
(consistent with the conclusions of previous studies [Fazilleau
et al., 2009; Tubo et al., 2013]), whereas Nur77-GFP levels
were declining in cells without a Tfh cell phenotype. However,
at an earlier time point (day 7), Nur77-GFP expression was
similar in Tfh and non-Tfh cells (Figure 3C), suggesting that
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Figure 3. Downregulation of KLF2 and
S1PR1 Expression Is Maintained in Tfh
Cells
(A) Expression of KLF2-GFP (top) or S1PR1-GFP
(bottom) by TEa CD4+ T cells at indicated time
points after Ea-SA-DEL and CFA immunization.
TEa cells were co-transferred with MD4 B cells
into WT B6 recipients prior to priming. Data are
presented as gMFI minus background gMFI of
non-transgenic TEa CD4+ T cells co-transferred
after gating on the indicated phenotypic subsets
(defined in Figure 1) was performed. Statistical
significance was calculated relative to the non-Tfh
population.
(B) Cell-surface expression of CD69 on Tfh and
non-Tfh TEa CD4+ T cells at days 2, 7, and 14 after
Ea-SA-DEL and CFA immunization, presented as
gMFI.
(C) Expression of Nur77-GFP (a reporter for TCR
signaling) by Tfh and non-Tfh TEa CD4+ T cells
(shown as gMFI, calculated as above).
(D and E) KLF2-GFP TEa and MD4 B cell recipient
mice were immunized with Ea-SA-DEL and CFA
and treated with anti-ICOSL (ICOS-L blocking)
or isotype control immunoglobulin at day 7 as
schematically shown in Figure S2D. KLF2-GFP
expression in Tfh or non-Tfh cells was analyzed
9 days after immunization.
(E) Data are presented as gMFI minus back-
ground gMFI of wild-type CD4 T cells of the
recipient mice. Data are from three independent
experiments with a total of nine recipient mice at
each time point. Graphs show accumulated (A–C
and E) or representative (D) data from the inde-
pendent experiments as means ± SD (A) or ±
SEM (B, C, and E). Statistical significance,
determined with a two-tailed t test, is indicated
as follows: ns, not significant (p > 0.05); *p < 0.05;
**p < 0.01; and ***p < 0.001.other factors might contribute to KLF2 downregulation. Tfh
differentiation and maintenance also require ICOS signaling,
typically induced as T cells encounter ICOS-L expressed on
follicular B cells (Crotty, 2011; Liu et al., 2013; Victora and
Nussenzweig, 2012; Vinuesa and Cyster, 2011). ICOS activates
the phosphoinositide 3-kinase (PI3K) pathway, which is known
to extinguish KLF2 expression (Fabre et al., 2008; Sinclair et al.,
2008; Skon et al., 2013). Hence, we tested how ICOS-L
blockade, initiated at day 7 of immunization, would impact
KLF2 expression and Tfh differentiation (Figure S2D). 5 days
of ICOS-L blockade caused substantial loss of cells with a
Tfh cell phenotype (Figure S2E), confirming the relevance of
this pathway for Tfh cell maintenance but limiting our capacity
to assess changes in KLF2 expression in the Tfh cell pool.
However, after short-term ICOS-L blockade, a substantial Tfh
cell population remained (Figure S2E), and those cells showed
a marked increase in KLF2 expression compared to that of
controls (Figures 3D and 3E). No change in KLF2 expression
was observed in the non-Tfh-cell population. These data sug-gest that ICOS engagement plays a critical role in repressing
KLF2 expression during Tfh cell generation.
Loss of KLF2 Enhances Tfh Cell Generation and the GC
B Cell Response
Although these results indicated that Tfh characteristically
display reduced KLF2 and S1PR1 expression, the functional
relevance of this expression pattern was unclear. Hence, we
examined the consequences of dysregulated KLF2 expression.
Analysis of KLF2-deficient naive T cells is compromised by their
altered trafficking (Bai et al., 2007; Carlson et al., 2006), and so
we utilized an inducible-knockout approach in which tamoxifen
administration stimulates ERT2-Cre to mediate Klf2 ablation
(monitored through a Cre-induced YFP reporter: Figures S3A
and S3B) (Liu et al., 2014; Wang et al., 2014). Klf2 deletion in
TEa T CD4+ T cells was initiated at day 2 of the response
(when the KLF2 expression level is already low; Figure 3A and
S3A). Ablation of Klf2 led to a striking increase in the frequency
(Figure 4A) of CD4+ T cells with a Tfh cell phenotype versusImmunity 42, 252–264, February 17, 2015 ª2015 Elsevier Inc. 255
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Figure 4. Inducible KLF2 Deletion in CD4+ T Cells Enhances Tfh Cell Differentiation and the GC B Cell Response
(A) WT CD4+ TEa cells (Cre-ERT2 TEa) or KLF2-inducible knockout CD4+ TEa cells (Klf2fl/fl Cre-ERT2 Rosa26-YFP TEa) were co-transferred with MD4 B cells into
wild-type B6 recipients and primed with Ea-SA-DEL and CFA subcutaneous immunization. Tamoxifen was administrated daily from day 2, and the cells were
analyzed at day 7. KLF2-deficient TEa CD4+ T cells were identified as YFP+.
(B–E) WT or KLF2-inducible knockout KLF2 TEa cells were transferred (without MD4 B cells) into Tcra/ (B, C, and D) or Tcrb/ (E) recipients, which were
immunized with Ea-SA-DEL in CFA and treated with tamoxifen from days 2 to 6. Animals were analyzed on day 7 (B–D) or days 14 and 30 (E) for phenotypic
markers (defined in Figure S3. (B) Titers of Ea-SA-DEL-specific antibodies in serum from mice receiving wild-type (n = 5) or Klf2 fl/fl (n = 5) TEa T cells. Serum
samples were collected at the day of immunization (pre-immune), beginning of tamoxifen treatment (day 2 after immunization: ‘‘D + 2’’), and after 5 days of
tamoxifen treatment (day 7 after immunization: ‘‘D + 7’’). (C and D) Quantification of endogenous Ea-SA-specific (C) plasma cells (intracellular immunoglobulin
[Ighi, B220lo]; left] and (D) GC B cells (B220hi, GL7hi; right) in Tcra/ knockout recipient mice at day 7 after immunization. (E) Quantification of endogenous Ea-SA-
specific isotype-switched memory B cell (B220hi, CD38hi, IgMneg, IgDneg) in TCRb knockout recipient mice at days 14 and 30 after immunization. Each symbol
represents an individual mouse, and small horizontal lines indicate the mean. Data are from three independent experiments with a total of nine wild-type B6
recipient mice (A), with nine wild-type or six Klf2fl/fl Tcra/ recipient mice (B–D), or with 15 KLF2+/+ or 15 Klf2fl/fl Tcrb/ recipient mice (E). Graphs show
accumulated data from the independent experiments asmeans ± SEM. Statistical significance, determined with a two-tailed t test, is indicated as follows: ns, not
significant (p > 0.05); *p < 0.05; **p < 0.01; and ***p < 0.001.controls, consistent with the hypothesis that KLF2 acts to
restrain Tfh cell differentiation.
To test whether KLF2-deficient Tfh CD4+ T cells were func-
tional, we tested their capacity to mediate antigen-specific B
cell priming and the GC reaction. Klf2-inducible knockout TEa
T cells were transferred into TCRa- (or TCRb)-deficient recipients
and primed with Ea-SA-DEL. In this way, the antigen-specific
response of endogenous polyclonal B cells could be monitored,
whereas T cell help was limited to the donor population. As
expected, induced Klf2 deletion increased the frequency and256 Immunity 42, 252–264, February 17, 2015 ª2015 Elsevier Inc.number of Tfh phenotype CD4+ T cells compared to controls
(Figures S3C and S3D). Serum anti-Ea-SA-DEL IgM, IgG1,
IgG2a, IgG2c, and IgG3 as well as IgE titers were increased
within 5 days of induced KLF2 knockout (Figures 4B and S3E).
Moreover, inducible KLF2 deletion in donor TEa cells increased
the number of both plasma cells (Figure 4C) and GC B cells (Fig-
ure 4D) within the Ea-SA-specific polyclonal B cell population
(Figure S3F). Similar effects were seen at day 14 of the res-
ponse (data not shown). Furthermore, at later time points (days
14 and 30 after immunization), the number of antigen-specific
A B
C
Figure 5. Forced Expression of KLF2 or
S1PR1 Inhibits Tfh Cell Differentiation
(A) TEa CD4+ T cells were activated in vitro and
transduced with MiT-based retroviruses encoding
KLF2, S1Pr1, or no insert (empty) and adoptively
transferred (with naive MD4 B cells) in recipient
mice that were immunized with Ea-SA-DEL in
CFA. At day 7 of the response, transduced
TEa cells (identified by the Thy-1.1 marker)
were analyzed for phenotypic markers (defined in
Figure 1).
(B) Analysis of TEa CD4+ T cells for expression of
lineage-defining transcription factors after trans-
duction with indicated retroviruses at day 7 after
immunization in vivo. The gating strategy for each
population is described in Figure S4B.
(C) Effect of FTY720 treatment (S1PR1 blocking)
on representation of Tfh cell and non-Tfh-cell
populations within the retrovirally transduced TEa
T cells in vivo. FTY720 or vehicle control (Veh.)
was administrated by intra-peritoneal injection at
days 2, 4, and 6 after immunization, and the
phenotype of donor cells was analyzed at day 7
after the immunization. Data are from at least three
independent experiments with a total of 11 (A) or
nine (B) recipient mice, and graphs show accu-
mulated data from the independent experiments
as means ± SEM. Statistical significance, deter-
mined with a two-tailed t test, is indicated as ***p <
0.001.isotype-switched memory B cells was substantially increased
when KLF2-deficient TEa cells (rather than wild-type TEa cells)
were present (Figure 4E). Taken together, these results showed
that deletion of KLF2 in early-activated CD4+ T cells promoted
polarization toward Tfh cells and that those T cell populations
were functional and thus provided help for robust antigen-spe-
cific B cell priming, GC-dependent isotype switching, and gener-
ation of memory B cells.
Forced Expression of KLF2 or S1PR1 in CD4+ T Cells
Impairs Generation of Tfh Cells
As a complementary approach, we assessed the impact of
increased KLF2 expression on GC Tfh cell differentiation in vivo
by using a retroviral overexpression system (Skon et al., 2013). At
day 7 after immunization, forced expression of KLF2 in TEa CD4+
T cells resulted in a dramatic inhibition of Tfh cell differentiation
(as compared to non-transduced and ‘‘empty’’ retroviral trans-
duced controls) (Figures 5A and S4A), supporting the proposal
that KLF2 plays a dominant-negative regulatory role in Tfh
cell differentiation. KLF2 is required for S1PR1 expression in
T cells, and previous studies have suggested that induction of
S1PR1 is sufficient to substitute for KLF2 in promoting thymo-
cyte egress (Zachariah and Cyster, 2010) and inhibiting Trm
generation (Skon et al., 2013). Indeed, ectopic expression of
S1PR1, like KLF2, significantly decreased generation of Tfh
CD4+ T cells (Figures 5A and S4A). An important question was
what Th cell subset was favored by KLF2 overexpression. To
assess this, we analyzed the expression of lineage-defining tran-
scription factors in responding CD4+ T cells by using a sequential
gating strategy (Figure S4B), revealing that forced KLF2 expres-sion caused a substantial increase in the frequency of T-bet+
cells (indicative of Th1 differentiation) and a reduction in the fre-
quency of RORgt+ cells (associated with the Th17 subset) (Fig-
ure 5B). A small increase in the frequency of T-bet-, GATA3+ cells
was also observed. Forced expression of S1PR1 had a minimal
effect on the frequency of T-bet+, GATA3+, or RORgt+ popula-
tions, but KLF2 and S1PR1 overexpression each resulted in
a reduced frequency of Bcl-6+ cells, in keeping with impaired
Tfh differentiation (Figure 5B). These results suggest that down-
regulation of KLF2 and its target S1PR1 are obligatory steps in
the production of Tfh CD4+ T cells and that enforced KLF2
expression favors generation of cells expressing the canonical
Th1 cell transcription factor T-bet.
KLF2 Inhibits Tfh cell Production Independently of
S1PR1 Regulation
These findings might suggest that the critical function of KLF2
in controlling Tfh cell production is through control of S1PR1
expression. To test this, we neutralized S1PR1 functional activity
with the drug FTY720 (Cyster and Schwab, 2012). Although
S1PR1 overexpression led to reduced generation of Tfh, this ef-
fect was substantially reversed by treatment with FTY720 (Fig-
ures 5C and S4C), consistent with the hypothesis that S1PR1
expression blocks Tfh cell generation. Surprisingly, however,
FTY720 treatment had no effect on the skewed Tfh cell differen-
tiation induced by forced KLF2 expression (Figures 5C and S4C).
This implied that the effects of forced KLF2 expression were
not limited to induction of S1PR1. It is unlikely this is simply a
consequence of insufficient FTY720 dosage because mRNA
expression for S1PR1 was lower in KLF2-transduced than inImmunity 42, 252–264, February 17, 2015 ª2015 Elsevier Inc. 257
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Figure 6. Transcriptional Regulation of Blimp-1 by KLF2
(A and B) RT-PCR analysis of various genes (horizontal axis) for in-vitro-cultured retrovirus-transduced (A) or KLF2 knockout (B) TEa CD4+ T cells after sorting on
the basis of the expression of retroviral transduction marker (Thy1.1) or Cre-reporter signal (for Klf2/ YFP+). Detailed in vitro culture conditions are described in
Figure S5A.
(C) Induction of Blimp-1 in the retrovirus-infected Blimp-1-YFP reporter CD4+ T cells (identified by Thy1.1+ expression) in vitro.
(D) ChIP analysis of naive or in-vitro-activated KLF2GFP-reporter TEa CD4+ T cells, followed by chromatin immunoprecipitationwith rabbit immunoglobulin G (IgG;
control) or anti-GFP and quantitative PCR analysis of binding at the promotor regions of each gene (horizontal axis) (primers are listed in the Experimental
Procedures). Results were normalized to those of a standardized aliquot of input chromatin, and subtraction of the signal obtained with IgG (nonspecific
background) followed.
(E) prdm1fl/fl Bcl6+/ SMARTA CD4+ T cells that were activated in vitro and co-transduced with MiT-based retroviruses encoding KLF2 (or no insert [empty RV])
and Cre-expressing retrovirus (MSCV-Cre-IRES-mAmetrine; Cre RV) were adoptively transferred in recipient mice and primed by LCMV infection. At day 7 of the
response, transduced wild-type (Cre; mAmetrine-negative) or Prdm1/ (Cre+; mAmetrine-positive) SMARTA cells (identified by the Thy-1.1 and mAmetrine
expression) were analyzed for phenotypic markers (defined in Figures S5C and S5D). All experiments were repeated at least three times with similar results.
Graphs show accumulated data from the independent experiments as means ± SEM. Statistical significance, determined with a two-tailed t test, is indicated as
follows: ns, not significant (p > 0.05); *p < 0.05; **p < 0.01; and ***p < 0.001.S1PR1-transduced CD4+ T cells (see Figure 6A). Furthermore,
FTY720 treatment did not impact CD4+ T cell differentiation in
the control-transduced population (Figures 5C and S4C), sug-
gesting that S1PR1 function alone was not regulating generation
of the Tfh cell subset in normal cells. These data indicate that
S1PR1 downregulation is necessary but not sufficient to permit
Tfh differentiation but that S1PR1 regulation was not the domi-
nant pathway through which KLF2 regulates generation of the
Tfh cell subset.
KLF2 Induces Blimp-1 to Reduce Bcl-6 Expression
Our findings suggested that KLF2 might have additional down-
stream targets that affect Tfh cell generation. We assessed the
impact of KLF2 overexpression or deletion on the expression
of known factors in the Tfh differentiation pathway by using in-vi-258 Immunity 42, 252–264, February 17, 2015 ª2015 Elsevier Inc.tro-stimulated CD4+ T cells maintained in non-polarizing culture
conditions (Figures 6A–6C and S5A). Quantitative RT-PCR data
showed that KLF2 overexpression led to significantly increased
expression of Prdm1 (the gene encoding Blimp-1) and reduced
expression of Bcl6 (Figures 6A and 6C). In contrast, KLF2 abla-
tion led to a reduction in Blimp-1 expression and induction of
Bcl6 (Figure 6B). Hence, these data indicate that KLF2 regulates
the expression of transcription factors that dominantly regulate
Tfh cell differentiation (Crotty, 2011; Johnston et al., 2009; Oes-
treich et al., 2012). In contrast, we did not observe effects of
KLF2 manipulation on mRNA expression of Ascl2, CXCR5,
ICOS, or IL-21 in these in-vitro-cultured cells (Figures 6A and
6B and data not shown). Forced expression of S1PR1 had no
effect on Blimp-1 or Bcl-6 expression (Figures 6A and 6C).
Although these data showed that KLF2 impacts the balance of
Blimp-1 and Bcl-6 expression, the transcriptional antagonism
between those two factors complicates defining how KLF2
regulates this expression profile. To test whether KLF2 directly
binds to promoters for these genes, we performed chromatin
immunoprecipitation (ChIP) assays for KLF2-GFP on both naive
and activated CD4+ T cells by using PCR probes for regions
close to proposed transcriptional start sites (Figure S5B). As ex-
pected, we found KLF2 at the promoter of S1pr1 in naive and
activated CD4+ T cells (Figure 6D). In addition, we found that
KLF2 bound the promoter region of Prdm1, the gene encoding
Blimp-1, after T cell activation, but we did not observe a signifi-
cant ChIP signal for KLF2 at theBcl6 promoter (Figure 6D). These
findings are consistent with the idea that changes in Bcl6mRNA
expression (Figures 6A and 6B) are secondary to KLF2 induction
of the repressor Blimp-1, and they raised the question of whether
the ability of KLF2 overexpression to impair Tfh differentiation
required Blimp-1. To explore this question, we used a retroviral
co-transduction system, allowing for both overexpression of
KLF2 and expression of Cre recombinase in cells with floxed
Prdm1 alleles, to induce Prdm1 deletion (Johnston et al.,
2012). Transduction with KLF2 and Cre retroviruses was moni-
tored by the markers Thy-1.1 and mAmetrine, respectively (Fig-
ure S5C). SMARTA TCR transgenic Prdm1fl/fl cells were used,
and the response to LCMV infection wasmonitored at day 7 after
infection (Figure S5C). Cells transduced with Cre alone showed
increased Tfh cell differentiation, consistent withPrdm1 deletion,
whereas cells transducedwith KLF2 alone exhibited reduced Tfh
generation, as expected (Figures 6E and S5C). However, the Tfh
population frequency in cells transduced with both retroviruses
was considerably higher than that of those transduced with
KLF2 alone, indicating that Blimp-1 is critical for the effects of
KLF2 overexpression (Figure 6E). Still, a trend toward lower Tfh
frequency in dual-transduced cells compared to those trans-
duced with Cre alone suggested that forced KLF2 expression
might also operate through Blimp-1-independent pathways to
impair Tfh generation.
KLF2 Promotes Expression of T-bet and Gata3 and Th1
Generation
Our studies showed that KLF2 overexpression in vivo leads to an
increased frequency of T-bet- and GATA3-expressing CD4+
T cells (Figure 5B), and so we also explored how expression of
transcription factors that define other T helper (Th) cell subsets
was affected by KLF2manipulation (Figures 7A and 7B). Overex-
pression of KLF2 in vitro led to a substantial increase in expres-
sion of T-Bet (Tbx21) andGata3 genes and proteins, but it did not
affect expression of the gene for Rorgt (Rorc) or Foxp3 (Figures
7A and 7C and data not shown). We saw an increase in the fre-
quency of cells co-expressing T-bet and GATA3 (Figure 7D), and
ChIP assays revealed that KLF2 occupies the regulatory regions
of the genes for T-bet (Tbx21) and GATA3 (Gata3) after T cell
activation (Figure 7E). However, induced KLF2 deficiency did
not lead to reduced expression of Tbx21 or Gata3 (Figure 7B),
in contrast with the decline in Prdm1 expression (Figure 6A), sug-
gesting KLF2 is not required for Tbx21 or Gata3 expression.
Next we assessed whether KLF2 manipulation led to altered
effector function. TEa CD4+ T cells were activated and trans-
duced with empty, KLF2, or S1Pr1 retroviruses, cultured in
non-polarizing (‘‘Th0’’) or Th1-polarizing conditions, and then as-sayed for production of IFN-g or IL-4 after restimulation. Forced
expression of KLF2 (but not of S1Pr1) led to a substantial in-
crease in the frequency of IFN-g-producing cells from the Th0
cultures,and increased IFN-g expression levels in cells from
both Th0 and Th1-polarized cultures (Figure 7F). In contrast,
induced deletion of KLF2 in Th1-polarized CD4+ T cells led to
both a reduced frequency of IFN-g-producing cells and reduced
IFN-g expression levels in those cells (Figure 7F). IL-4 production
was not detected from any groups under these culture condi-
tions (Figures S6A and S6B). Forced KLF2 expression also led
to enhanced Th1 differentiation in vivo, as indicated by the
increased frequency of IFN-g-producing cells and elevated
IFN-g expression levels induced in cells recovered 7 days after
immunization (Figure 7G).
KLF2 overexpression might induce non-physiological gen-
e-expression patterns. Hence, we also evaluated whether en-
dogenous KLF2 expression correlated with expression of line-
age-defining transcription factors in differentiating TEa CD4+
T cells. KLF2 expression was lowest in the Bcl-6hi pool, corre-
sponding to Tfh cells (Figure 7H). In contrast, TEa CD4+ T cells
co-expressing T-Bet andGATA3 exhibited high KLF2 expression
(Figures 7H and S6E). Other transcription-factor-defined sub-
sets showed intermediate expression of endogenous KLF2 (Fig-
ure 7H). These data support the hypothesis that physiological
KLF2 expression levels correspond with expression of the Th-
lineage-defining transcription factors that are direct targets of
KLF2.
DISCUSSION
The factors regulating Tfh cell differentiation and localization
within the GC are still being defined. In this report, we show
that one transcription factor, KLF2, influences both activated
CD4+ T cell trafficking (through regulation of S1PR1) and Th
subset differentiation (through control of Blimp-1, T-bet, and
Gata3), such that KLF2 expression directs differentiating CD4+
T cells away from the Tfh cell fate. Our findings are consistent
with studies showing low expression of Klf2 and S1pr1 tran-
scripts in Tfh cells (Kitano et al., 2011; Xiao et al., 2014), although
those reports did not explore the significance of those findings.
Furthermore, KLF2 does not simply block Tfh cell differen-
tiation but, through regulation of multiple key transcription fac-
tors, serves to shape alternative Th-cell-differentiation choices.
Indeed, we find that the amount of endogenous KLF2 expression
correlates with expression of lineage-defining transcription fac-
tors, suggesting that KLF2 levels can tune the Th-cell-subset dif-
ferentiation fate.
We and others have reported that KLF2 regulates expression
of S1PR1, which is critical for lymphocyte recirculation (Bai
et al., 2007; Carlson et al., 2006; Skon et al., 2013; Zachariah
and Cyster, 2009). Indeed, with regard to thymocyte egress
and establishment of Trm, expression of S1PR1 largely accounts
for the role of KLF2 (Skon et al., 2013; Zachariah and Cyster,
2009, 2010). We found that forced expression of S1PR1 in acti-
vated CD4+ T cells led to a dramatic reduction in generation of
Tfh cells. S1PR1 expression might impair migration of activated
T cells into the B cell follicle, thereby blunting the signals that nor-
mally sustain Tfh cell differentiation. S1PR1 signals override
migration induced by CXCR5 in MZ B cells (Arnon et al., 2013)Immunity 42, 252–264, February 17, 2015 ª2015 Elsevier Inc. 259
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Figure 7. KLF2 Induces T-bet and GATA3 Expression and Enhances Th1 Polarization during CD4+ T Cell Lineage Commitment In Vivo
(A and B) RT-PCR analysis of CD4+-T-cell-lineage-specific transcription-factor expression (horizontal axis) for in-vitro-cultured retrovirus-transduced (A) or KLF2
knockout (B) TEa CD4+ T cells after cells were sorted on the basis of the expression of retroviral transduction marker (Thy1.1) or Cre-reporter signal (for Klf2/
YFP+). Detailed in vitro culture conditions are described in Figure S5A.
(C) Fluorescence-activated cell sorting (FACS) analysis of T-Bet and GATA3 expression in retrovirally transduced TEa cells (identified by Thy1.1+ expression).
(D) Frequency of T-bet+, GATA3+ TEa CD4+ T cells within the T-bet+ population (Th1; T-bet+FoxP3RORgT).
(E) ChIP-PCR analysis of naive or in-vitro-activated KLF2-GFP reporter TEa CD4+ T cells, followed by chromatin immunoprecipitation with rabbit IgG (control) or
anti-GFP and quantitative PCR analysis of binding at the promotor regions of Tbx21 (T-bet) and Gata3 (GATA3) (primers are listed in the Supplemental Exper-
imental Procedures).
(legend continued on next page)
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and counteract responses through a related chemokine recep-
tor, CCR7, in T cells (Cyster and Schwab, 2012; Pham et al.,
2008). In addition, S1PR2 was shown to cooperate with
CXCR5 for efficient Tfh cell generation (Moriyama et al., 2014);
because S1PR1 and S1PR2 signal through distinct G protein
complexes, they could have opposing effects on cell migration
(Cyster and Schwab, 2012). Nevertheless, our data indicated
that S1PR1 regulation is insufficient to explain the effects of
KLF2 expression on Tfh cell differentiation.
Further studies showed that KLF2 affected several T-cell-line-
age-defining transcription factors. Overexpression of KLF2 led
to increased expression of Blimp-1, whereas induced ablation
of klf2 led to the opposite outcome. Bcl-6 expression changed
in the reciprocal direction, as expected from the known mutual
repression exerted between Bcl-6 and Blimp-1 (Crotty, 2011;
Johnston et al., 2009; Oestreich et al., 2012), but our data from
ChIP suggested that Blimp-1 was a direct target for KLF2 bind-
ing. Furthermore, studies with inducible Prdm1-deficient cells
demonstrated that the capacity of forced KLF2 to impair Tfh gen-
eration was largely dependent on Blimp-1. Previous studies on
CD8+ T cells showed that forced KLF2 caused elevated Blimp-
1 expression (Hu and Chen, 2013; Preston et al., 2013), consis-
tent with our results. However, recent studies on pre-B cells
found that KLF2 dramatically repressed (rather than promoted)
expression of Blimp-1 (Winkelmann et al., 2014), suggesting
the nature of Blimp-1 regulation by KLF2 might be specific to
cell type or developmental stage. We did not note changes in
gene expression in Ascl-2, CXCR5, ICOS, or IL-21 when KLF2
expression was manipulated, but it is possible that our in vitro
studies would not reveal those changes, and analysis of KLF2
binding to other genes involved in Tfh cell differentiation and
migration will be important. Nevertheless, our data on the impact
of KLF2 on the balance between Blimp-1 and Bcl-6 expression
provides a ready explanation for KLF20s ability to derail the Tfh
cell differentiation pathway.
Surprisingly, we also observed that elevated KLF2 expression
induced the T-bet and Gata3 transcription factors, and ChIP
assays suggested that KLF2 directly bound to the regulatory re-
gions for the genes encoding these factors. Our data suggest
that this regulation is not simply an artifact of overexpression
studies because analysis of normal TEa cells responding in vivo
showed that the populations expressing T-bet and Gata3
had significantly higher levels of endogenous KLF2. T-bet and
Gata3 are frequently co-expressed in human Th1 cells (Paliard
et al., 1988), but analysis in mouse T cells suggests that these
two factors are normally differentially expressed (i.e., Th1 cells
express T-bet, and Th2 cells express Gata3) (Zhu et al., 2010).
Although some studies have suggested that restimulating Th1
cells in Th2 conditions can provoke T-bet+Gata3+ cells with
hybrid Th1 and Th2 properties (Hegazy et al., 2010), our studies
found that KLF2-overexpressing CD4+ T cells were potentiated(F) Percentage of IFN-g producing population (left) or level of IFN- g production (r
KLF2 KO (bottom) TEa CD4+ T cells in vitro (FACS plots in Figures S6A and S6B
(G) Percentage of IFN-g-producing population (left) or level of IFN- g production in
the retrovirus-infected TEa CD4+ T cells in vivo (FACS plots in Figure S6C).
(H) KLF2-GFP expression (gMFI) within TEa CD4+ T cells expressing the indicate
independent experiments, and graphs show accumulated data from the indepen
two-tailed t test, is indicated as follows: ns, not significant (p > 0.05); *p < 0.05; afor production of the Th1 cytokine IFN-g but did not exhibit
detectable production of the Th2 cytokine IL-4. Studies on the
characteristics of T-bet+Gata3+ CD4+ T cells suggest that T-
bet typically co-opts Gata3 to support Th1-lineage gene expres-
sion (Kanhere et al., 2012), consistent with our findings. Although
Blimp-1 has been reported to directly repress expression of T-
bet and IFN-g in activated CD4+ T cells (Cimmino et al., 2008),
our studies indicate that, when induced by KLF2, Blimp-1 and
T-bet can be co-expressed. The significance of KLF2hi cells’ ex-
pressing T-bet and Gata3 will require further study, but these
findings suggest that KLF2 expression not only restrains Tfh dif-
ferentiation but also can foster differentiation into other Th cell
lineages (Th1 and potentially Th2). We observed that the fre-
quency of RORgt-expressing cells was reduced by forced
KLF2 expression (although whether this reflects active impair-
ment of Th17 cell differentiation versus preferential skewing to-
ward Th1 cell differentiation is not clear), and an intriguing recent
study showed that KLF2 is also critical for effective induction of
Foxp3 in induced Treg cells (Pabbisetty et al., 2014). Hence,
accumulating data suggest that KLF2 acts as a critical element
in differentiation into Th cell subsets.
What factors inhibit KLF2 expression during Tfh differentia-
tion? ICOS-ICOSL interactions are critical for Tfh cell generation,
and our studies showed that ICOS-L blockade led to increased
KLF2 expression in cells with a Tfh cell phenotype. ICOS
signaling induces the PI3K pathway (Crotty, 2011; Gigoux
et al., 2009), and several studies indicate that strong PI3K-Akt
activation impairs KLF2 expression, at least in part because of
degradation of the transcription factor Foxo1 (Fabre et al.,
2008; Kerdiles et al., 2009; Kerdiles et al., 2010; Sinclair et al.,
2008; Skon et al., 2013). Foxo1 ablation leads to substantially
enhanced Tfh differentiation (Kerdiles et al., 2010; Xiao et al.,
2014), and recent studies indicate that degradation of Foxo1
through action of the E3 ubiquitin ligase Itch was important for
Tfh differentiation and that Itch deficiency led to elevated expres-
sion of Foxo1 target genes (including KLF2) (Xiao et al., 2014).
Although we find that ICOS engagement is important for repres-
sion of KLF2, this is unlikely to be the only relevant factor. TCR
signaling also induces loss of KLF2 expression, and we find
evidence of sustained TCR signaling in cells with a Tfh cell
phenotype. Furthermore, studies with CD8+ T cells reveal that
exposure to various cytokines—including TGF-b, IL-33, IL-12,
IFN-I, and TNF—impairs KLF2 expression (Bai et al., 2007; Sin-
clair et al., 2008; Skon et al., 2013). Hence, the specific cytokine
milieu surrounding an activated CD4+ T cell could dictate its
KLF2 expression. Defining how disparate signals coordinate to
regulate KLF2 expression during Tfh cell differentiation will
require further investigation.
Kruppel-like factors play diverse roles inmultiple tissues, often
related to late differentiation steps (Hart et al., 2012; Skon et al.,
2013). The studies reported here demonstrate a significantight) upon PMA/Ionomycin stimulation for 3 hr in the retrovirus-infected (top) or
).
T-bet+ population (right) upon ex vivo PMA and Ionomycin stimulation for 3 hr in
d transcription factors at day 7 after immunization. Data are from at least three
dent experiments as means ± SEM. Statistical significance, determined with a
nd ***p < 0.001.
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impact of KLF2 expression on helper CD4+ T cell subset differen-
tiation in two separate ways: Through trafficking (via S1PR1) and
through regulation of three lineage-defining transcription factors
(Blimp-1, T-bet, and GATA3). Hence, KLF2 serves a hitherto un-
suspected function in dictating the lineage fate of CD4+ T cells.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6) and B6.SJL mice were purchased from the National Cancer
Institute, and ERT2-Cre, Rosa26-YFP, Blimp1-YFP, and Tcra/ mice were
obtained from Jackson Laboratories. Mice expressing the TEa TCR transgene,
specific for a peptide from the I-EaMHC II molecule bound to I-Ab (I-Ab-Ea, or
the MD4 BCR transgene, which recognizes duck egg lysozyme (DEL), were
maintained at the University of Minnesota. Cells from prdm1fl/flBcl6+/
SMARTA mice were provided by Drs. Phil Nance and Shane Crotty (La Jolla
Institute for Allergy and Immunology) (Johnston et al., 2012). The S1PR1-
GFP, KLF2-GFP, Nur77-GFP, andKlf2fl/fl mice have been previously described
(Cahalan et al., 2011; Moran et al., 2011; Skon et al., 2013; Weinreich et al.,
2010; Weinreich et al., 2009) and were crossed to TEa mice at the University
of Minnesota. Animals were maintained under specific-pathogen-free condi-
tions at the University of Minnesota. All experimental procedures were
approved by the institutional animal care and use committee at the University
of Minnesota.
Infections and MHC-II-Tetramer-Based Cell Enrichment
Mice were injected intravenously with 1 3 107 colony-forming units of ActA-
deficient LM-2W1S bacteria or intraperitoneally (i.p.) with 2 3 105 plaque-
forming units of the LCMV Armstrong strain. Tetramers composed of both
2W1S, LLO190-201, or LCMV glycoprotein (GP) 66–77 peptides and I-Ab
were made as described previously (Moon et al., 2009; Tubo et al., 2013).
Adoptive Transfer and Ea-SA-DEL Immunization
For adoptive transfer experiments, 1 3 105 TEa CD4+ T cells were typically
co-transferred with 5 3 104 MD4 B cells into WT B6, B6.SJL, or Tcra/
mice, depending on the CD45 congenic marker expression of the donor cells.
Inducible KLF2 Deletion and B Cell GC Reaction
In vivo KLF2 deletion of Klf2fl/fl (KLF2fl/fl ETR2-Cre Rosa26-YFP TEa) cells in
wild-type B6.SJL, Tcra/, or Tcrb/ mice was achieved by administration
of tamoxifen (10 cmg/ml) in sunflower seed oil i.p. for 5 consecutive days
from day 2 after immunization. At day 7 after immunization, the spleen and
inguinal, axillary, brachial, cervical, and mesenteric lymph nodes (LNs) were
harvested and analyzed. Sera from immunized mice were collected at days
0, 2, and 7 after immunization, and antigen-specific antibodies were measured
by ELISA as previously described (Pape et al., 2011).
Retroviral Transduction Approaches
Naive CD4+ T cells from TEa or Blimp1-YFP mice were isolated and activated
by plate-bound anti-CD3 and anti-CD28 with recombinant IL-2 (20 ng/ml).
24 hr after activation, cells were spin-infected by retroviruses MiT-KLF2,
MiT-S1PR1, or control empty vector (MiT-Empty) as described previously
(Skon et al., 2013).
Chromatin Immunoprecipitation and Quantitative RT-PCR
Chromatin immunoprecipitation (ChIP) was performed as previously
described (Li et al., 2013). Detailed procedures and primer information are
described in Supplemental Information.
Immunohistochemistry
KLF2-GFP or WT B6 mice were subcutaneously immunized with PE (15 mg in
CFA) at the base of the tail and were sacrificed after 14 days. Draining LNs
were fixed with 4%PFA and incubated in 30% sucrose solution. 5 mmsections
were cut and stained with anti-GFP antibody (Life Technology). GFP fluores-
cence intensities were quantified in GC (GL7 and B220 abundant) or T cell
zone (CD4+ abundant and B220 negative) CD4+ T cells with ImageJ software
according to histocytometric algorithms as previously described (Gerner et al.,
2012).262 Immunity 42, 252–264, February 17, 2015 ª2015 Elsevier Inc.Statistical Analysis
Data were analyzed with Prism software 4.0 (GraphPad). For standard data
sets, an unpaired two-tailed Student’s t test was used. For values that differed
by more than 10-fold, the data were log10-transformed before t test analysis.
When data were normalized (by the appropriate control samples), normaliza-
tion involved division of all values by the overall mean of the control values
so that type I and II errors during calculation of significance through the
t test would be avoided. Data sets (in Prism format) are available on request.
SUPPLEMENTAL INFORMATION
Supplemental Information include Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.immuni.2015.01.013.
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